Digital Ally Subsidiary, TicketSmarter®, Announces Agreement with Gannett Co., Inc.
Through Gannettand theUSA TODAY NETWORK,TicketSmarter will bring ticket opportunities tonational and local audiences
Lenexa, KS, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (NASDAQ: DGLY) (the “Company”), today announces TicketSmarter®, a subsidiary of Digital Ally, is integrating its ticket resale platform and branding with Gannett Co., Inc. across USATODAY.com, USA TODAY NETWORK’s 250+ local media sites and more than 70 vertical sports sites that reach over 145 million visitors each month.
In a first-of-its-kind agreement, TicketSmarter will provide visitors with an intuitive way to access information and tickets for sport, entertainment, and lifestyle events on its safe and secure platform. Integration across local media sites is currently underway and readers can access tickets directly from drop-down menus across the Sports and Entertainment sites.
“We believe that the future of ticketing is fast, easy and fan-centric,” said Jeff Goodman, TicketSmarter CEO, adding, “With Gannett, we will be able to give consumers unmatched access to our secondary resale marketplace so they can experience the power and excitement of live events.”
“We are excited to bring our ticketing platform to Gannett’s audience,” said Stan Ross, CEO of Digital Ally, adding, “This integration shows TicketSmarter’s commitment to developing meaningful and prospective relationships across all channels.”
Other noteworthy deals recently announced by TicketSmarter:
- Big Ten Conference & Big Ten Network – Official Secondary Ticket Resale Marketplace
- MLB Players, Inc. – MLB Players Local Marketplace Activation
- World Wide Technology Raceway – Official Ticket Resale Marketplace
- Reese’s Senior Bowl – Official Ticket Resale Marketplace
- Ivy League Conference – Official Ticket Resale Marketplace
- PacWest Conference – Official Ticket Resale Marketplace
- Southland Conference – Official Ticket Resale Marketplace
With 48 million tickets for sale for over 125,000 live events TicketSmarter® is a national ticket marketplace offering tickets for live events featuring sports, concerts and theater. TicketSmarter is the official ticket resell partner of Rose Bowl Stadium and the title sponsor of the TicketSmarter Birmingham Bowl with ESPN Events. Additionally, TicketSmarter is the official ticket resell partner of more than 35 collegiate conferences, 250+ universities, and hundreds of events, venues, and charities nationally – including St. Jude Children’s Research Hospital, V Foundation and Quarterbacking Children’s Health Foundation.
About Digital Ally
Digital Ally, Inc. through its subsidiaries, is engaged in vehicle and body cameras, flexible software storage, automatic recording technology and various critical safety products; Shield™ Health Protection Products line, including all natural cleansers, a non-contact temperature-screening device, an electrostatic sprayer and a variety of personal protective equipment. With its recent formation of Digital Ally Healthcare, Inc., a medical records company and acquisition of TicketSmarter®, LLC, a national ticket broker, Digital Ally continues to add organizations that demonstrate the common traits of positive earnings, growth potential and organizational synergies.
For additional news and information please visit www.digitalallyinc.com or follow additional Digital Ally Inc. social media channels here:
Jeff Goodman, CEO
Stanton Ross, CEO
Tom Heckman, CFO
Digital Ally, Inc.
This Press Release (the “Release”) of Digital Ally, Inc. (the “Company”, “we”, “us”, or “our”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “may,” “should,” “could,” “will,” “plan,” “future,” “continue,” and other expressions that are predictions of or indicate future events and trends and that do not relate to historical matters identify forward-looking statements. These forward-looking statements are based largely on our expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond our control. Therefore, actual results could differ materially from the forward-looking statements contained in this document, and readers are cautioned not to place undue reliance on such forward-looking statements.
We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. A wide variety of factors could cause or contribute to such differences and could adversely impact revenues, profitability, cash flows and capital needs. There can be no assurance that the forward-looking statements contained in this document will, in fact, transpire or prove to be accurate.
Factors that could cause or contribute to our actual results differing materially from those discussed herein or for our stock price to be adversely affected include, but are not limited to: (1) our losses in recent years, including during fiscal 2020 and 2019; (2) economic and other risks for our business from the effects of the COVID-19 pandemic, including the impacts on our law-enforcement and commercial customers, suppliers and employees and on our ability to raise capital as required; (3) our ability to increase revenues, increase our margins and return to consistent profitability in the current economic and competitive environment; (4) our operation in developing new markets and uncertainty as to market acceptance of our technology, new products and our ability to grow the TicketSmarter subsidiary; (5) the availability of funding from federal, state and local governments to facilitate the budgets of law enforcement agencies, including the timing, amount and restrictions on such funding; (6) our ability to deliver our new product offerings as scheduled in 2020, such as the Shield™ disinfectant/sanitizers products and ThermoVu™ temperature screening systems, whether such new products perform as planned or advertised and whether they will help increase our revenues; (7) whether we will be able to increase the sales, domestically and internationally, for our products in the future; (8) our ability to maintain or expand our share of the market for our products in the domestic and international markets in which we compete, including increasing our international revenues; (9) our ability to produce our products in a cost-effective manner; (10) competition from larger, more established companies with far greater economic and human resources; (11) our ability to attract and retain quality employees; (12) risks related to dealing with governmental entities as customers; (13) our expenditure of significant resources in anticipation of sales due to our lengthy sales cycle and the potential to receive no revenue in return; (14) characterization of our market by new products and rapid technological change; (15) our dependence on sales of our EVO-HD, DVM-800, FirstVu HD and DVM-250 products; (16) that stockholders may lose all or part of their investment if we are unable to compete in our markets and return to profitability; (17) defects in our products that could impair our ability to sell our products or could result in litigation and other significant costs; (18) our dependence on key personnel; (19) our reliance on third-party distributors and sales representatives for part of our marketing capability; (20) our dependence on a few manufacturers and suppliers for components of our products and our dependence on domestic and foreign manufacturers for certain of our products; (21) our ability to protect technology through patents and to protect our proprietary technology and information, such as trade secrets, through other similar means; (22) our ability to generate more recurring cloud and service revenues; (23) risks related to our license arrangements; (24) our revenues and operating results may fluctuate unexpectedly from quarter to quarter; (25) sufficient voting power by coalitions of a few of our larger stockholders, including directors and officers, to make corporate governance decisions that could have a significant effect on us and the other stockholders; (26) the sale of substantial amounts of our common stock, par value $0.001 per share (the “Common Stock”), that may have a depressive effect on the market price of the outstanding shares of our Common Stock; (27) the possible issuance of Common Stock subject to options and warrants that may dilute the interest of stockholders; (28) our nonpayment of dividends and lack of plans to pay dividends in the future; (29) future sale of a substantial number of shares of our Common Stock that could depress the trading price of our Common Stock, lower our value and make it more difficult for us to raise capital; (30) our additional securities available for issuance, which, if issued, could adversely affect the rights of the holders of our Common Stock; (31) the likely high volatility of our stock price due to a number of factors, including a relatively limited public float; (32) whether such technology will have a significant impact on our revenues in the long-term; and (33) indemnification of our officers and directors.